INS and Hypoglycemia: These recommendations are based on data showing that GLP-1RAs when combinedwith basal insulin either as separate agents or in fixed-ratio combinations offered bothimproved HbA1c efficacy and favorable effects on weight and hypoglycemia risk(166).